Home » Stocks » FLDM

Fluidigm Corporation (FLDM)

Stock Price: $6.18 USD 0.21 (3.52%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $6.25 +0.07 (1.13%) Jan 15, 6:14 PM
Market Cap 453.61M
Revenue (ttm) 125.98M
Net Income (ttm) -47.68M
Shares Out 72.49M
EPS (ttm) -0.67
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $6.18
Previous Close $5.97
Change ($) 0.21
Change (%) 3.52%
Day's Open 6.06
Day's Range 5.94 - 6.42
Day's Volume 1,386,055
52-Week Range 1.24 - 11.43

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensiv...

GlobeNewsWire - 1 week ago

Study Highlighting IMC Application in Both Protein and RNA Detection Conducted by Researchers at Fluidigm C enter of Excellence for  Imaging Mass Cytometry at Georgetown Lombardi Comprehensive...

GuruFocus - 4 weeks ago

Investors focused on tech growth stocks may want to consider the following businesses, as their quarterly revenue and net income have advanced strongly on a year-over-year basis.

Other stocks mentioned: IPHI, TENB
GlobeNewsWire - 1 month ago

SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensiv...

GlobeNewsWire - 1 month ago

SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in NASDAQ: FLDM shares.

Zacks Investment Research - 1 month ago

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Fluidigm (FLDM).

GlobeNewsWire - 1 month ago

Fluidigm Assay is Among First Saliva-Based COVID-19 Tests Licensed for Use by Designated Labs in India Fluidigm Assay is Among First Saliva-Based COVID-19 Tests Licensed for Use by Designated ...

GlobeNewsWire - 1 month ago

SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensiv...

Newsfile Corp - 1 month ago

Los Angeles, California--(Newsfile Corp. - November 20, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fluid...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - November 20, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - November 20, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fluidigm Corporation ("Fluid...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - November 19, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fluidigm Corporation (NASDAQ: ...

Business Wire - 1 month ago

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fluidigm Corporation ("Fluidigm” or "the Company") (NASDAQ: ...

Newsfile Corp - 1 month ago

New York, New York--(Newsfile Corp. - November 19, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) betwee...

Newsfile Corp - 1 month ago

Los Angeles, California--(Newsfile Corp. - November 19, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fluid...

GlobeNewsWire - 1 month ago

Weill Cornell Medicine Researchers Utilize Fluidigm Hyperion Imaging System to Identify a Phenotype of Immune Cell Activity Distinct from Other Lung Infections

PRNewsWire - 1 month ago

LOS ANGELES, Nov. 18, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action ...

Newsfile Corp - 1 month ago

Los Angeles, California--(Newsfile Corp. - November 18, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Fluid...

Business Wire - 1 month ago

LOS ANGELES--(BUSINESS WIRE)---- $FLDM #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class ...

GlobeNewsWire - 1 month ago

SOUTH SAN FRANCISCO, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensiv...

PRNewsWire - 2 months ago

NEW YORK, Nov. 13, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 ...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - November 13, 2020) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motio...

PRNewsWire - 2 months ago

NEW YORK, Nov. 10, 2020 /PRNewswire/ --Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities cl...

GlobeNewsWire - 2 months ago

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensiv...

Seeking Alpha - 2 months ago

Fluidigm Corporation (FLDM) CEO Chris Linthwaite on Q3 2020 Results - Earnings Call Transcript

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - November 6, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between...

Zacks Investment Research - 2 months ago

Fluidigm (FLDM) delivered earnings and revenue surprises of 150.00% and 19.13%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

CNBC Television - 2 months ago

Cramer on four coronavirus testing stocks worth owning

"I bet the testing stocks have a lot more room to run," the "Mad Money" host said.

Other stocks mentioned: ABT, DGX, HOLX, LH, PKI, QDEL, TMO
Benzinga - 2 months ago

Shares of Fluidigm (NASDAQ:FLDM) rose 1.47% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 133.33% over the past year to $0.03, which ...

GlobeNewsWire - 2 months ago

Patients Receive Results, Education and Next Steps on Their Mobile Phones to Prevent Further Spread of the Disease Patients Receive Results, Education and Next Steps on Their Mobile Phones to ...

GlobeNewsWire - 2 months ago

25 Trials Utilizing Mass Cytometry Initiated in 2020 25 Trials Utilizing Mass Cytometry Initiated in 2020

GlobeNewsWire - 2 months ago

Global Pioneer in Direct-to-Consumer Genomic Testing Chooses Fluidigm Saliva-Based Solution

PRNewsWire - 2 months ago

NEW YORK, Oct. 31, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fluidigm Corporation ("Fluidigm" or the "Company") (NASDAQ: FLDM). Such investors are ad...

Zacks Investment Research - 2 months ago

Fluidigm (FLDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - October 28, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) betwee...

PRNewsWire - 2 months ago

NEW YORK, Oct. 26, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 ...

Newsfile Corp - 2 months ago

New York, New York--(Newsfile Corp. - October 22, 2020) -  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) betwee...

PRNewsWire - 2 months ago

LOS ANGELES, Oct. 21, 2020 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise a...

PRNewsWire - 3 months ago

NEW YORK, Oct. 9, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 a...

GlobeNewsWire - 3 months ago

Fluidigm COVID-19 Campus Safeguard Program Improves Availability of Non i nvasive, Saliva-Based SARS-CoV-2 Test s for Higher Education Institutions

PRNewsWire - 3 months ago

BENSALEM, Pa., Oct. 7, 2020 /PRNewswire/ -- Law Offices of Howard G. Smith reminds investors of the upcoming November 20, 2020 deadline to file a lead plaintiff motion in the class action file...

GlobeNewsWire - 3 months ago

SOUTH SAN FRANCISCO, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensiv...

PRNewsWire - 3 months ago

NEW YORK, Oct. 5, 2020 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Fluidigm Corporation ("Fluidigm" or the "Company") (NAS...

Business Wire - 3 months ago

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fluidigm Corporation (NASDAQ: FLDM) between February 7, 2019 and November ...

The Motley Fool - 3 months ago

You know what they say! To the most sensitive tests go the spoils.

Other stocks mentioned: BDX, HOLX, LLY, LMNX, PKI, QDEL, QGEN
Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - October 2, 2020) -  Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the secur...

Business Wire - 3 months ago

NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fluidigm Corporation ("Fluidigm” or "the Company") (NASDAQ: ...

PRNewsWire - 3 months ago

NEW YORK, Sept. 30, 2020 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court f...

Newsfile Corp - 3 months ago

New York, New York--(Newsfile Corp. - September 30, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Fluidigm Corporation ("Flui...

Benzinga - 3 months ago

Citron Research founder and activist short seller Andrew Left discussed his latest ideas during an appearance on Benzinga’s PreMarket Prep show Tuesday morning. Left has gained notoriety over ...

Other stocks mentioned: INO

About FLDM

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow., as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments... [Read more...]

Industry
Diagnostics & Research
IPO Date
Feb 10, 2011
CEO
Stephen Linthwaite
Employees
566
Stock Exchange
NASDAQ
Ticker Symbol
FLDM
Full Company Profile

Financial Performance

In 2019, Fluidigm's revenue was $117.24 million, an increase of 3.79% compared to the previous year's $112.96 million. Losses were -$64.79 million, 9.79% more than in 2018.

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Fluidigm stock is "Strong Buy." The 12-month stock price forecast is 13.00, which is an increase of 110.36% from the latest price.

Price Target
$13.00
(110.36% upside)
Analyst Consensus: Strong Buy